Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F SANDERS

Showing results (71-80 of 235) with videos related to

Pageof 24
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2007
Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitisPatricia M Stassen, Jan-Stephan F Sanders, Cees G M Kallenberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2015
Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?Anoek A E de Joode, Jan Stephan F Sanders, Abraham Rutgers, et al.
Arthritis Care & Research|December 14, 2011
Pregnancy in women diagnosed with antineutrophil cytoplasmic antibody-associated vasculitis: outcome for the mother and the childJ Tuin, J S F Sanders, A A E de Joode, et al.
Rheumatology (Oxford, England)|January 10, 2006
Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatmentJ-S F Sanders, M G Huitma, C G M Kallenberg, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapseJ-S F Sanders, M G Huitma, C G M Kallenberg, et al.
Nephron. Clinical Practice|November 18, 2014
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatmentJ S F Sanders, W H Abdulahad, C A Stegeman, et al.
Environmental Science & Technology|June 8, 2004
Locating sources of surf zone pollution: a mass budget analysis of fecal indicator bacteria at Huntington Beach, CaliforniaJoon Ha Kim, Stanley B Grant, Charles D McGee, et al.
Journal of Clinical Apheresis|February 6, 2014
Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppressionAnoek A E de Joode, Jan S F Sanders, W Martin Smid, et al.
Plant Disease|February 17, 2019
First Report of Colletotrichum gloeosporioides Causing 'Twister Disease' of Onion (Allium cepa) in GeorgiaC Nischwitz, D Langston, H F Sanders, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 30, 2016
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated VasculitidesJanneke Tuin, Jan-Stephan F Sanders, André P van Beek, et al.
Pageof 24

Showing results (71-80 of 235) with videos related to

Sort By:
Pageof 24
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2007
Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitisPatricia M Stassen, Jan-Stephan F Sanders, Cees G M Kallenberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2015
Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?Anoek A E de Joode, Jan Stephan F Sanders, Abraham Rutgers, et al.
Arthritis Care & Research|December 14, 2011
Pregnancy in women diagnosed with antineutrophil cytoplasmic antibody-associated vasculitis: outcome for the mother and the childJ Tuin, J S F Sanders, A A E de Joode, et al.
Rheumatology (Oxford, England)|January 10, 2006
Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatmentJ-S F Sanders, M G Huitma, C G M Kallenberg, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapseJ-S F Sanders, M G Huitma, C G M Kallenberg, et al.
Nephron. Clinical Practice|November 18, 2014
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatmentJ S F Sanders, W H Abdulahad, C A Stegeman, et al.
Environmental Science & Technology|June 8, 2004
Locating sources of surf zone pollution: a mass budget analysis of fecal indicator bacteria at Huntington Beach, CaliforniaJoon Ha Kim, Stanley B Grant, Charles D McGee, et al.
Journal of Clinical Apheresis|February 6, 2014
Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppressionAnoek A E de Joode, Jan S F Sanders, W Martin Smid, et al.
Plant Disease|February 17, 2019
First Report of Colletotrichum gloeosporioides Causing 'Twister Disease' of Onion (Allium cepa) in GeorgiaC Nischwitz, D Langston, H F Sanders, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 30, 2016
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated VasculitidesJanneke Tuin, Jan-Stephan F Sanders, André P van Beek, et al.
Pageof 24